Alpha-9 Oncology
Alison Fleming is the current Chief Operating Officer at Alpha-9 Theranostics Inc. Previously, Alison held the position of Chief Technical Officer at Collegium Pharmaceutical, Inc. where Alison played a crucial role in the development and commercial manufacturing of various pharmaceutical products. With a background in Chemical and Biomolecular Engineering, Alison has a strong foundation in product research and development, project management, and regulatory efforts. Alison has contributed significantly to the growth and success of pharmaceutical companies throughout their career.